Skip to main content
. 2024 Apr 26;5(3):100300. doi: 10.1016/j.xhgg.2024.100300

Figure 2.

Figure 2

HLA-B∗15:01 is not enriched in asymptomatic cases

(A) Allele frequency and 95% confidence intervals in the US prospective cohort European subgroups.

(B) Allele frequency and 95% CIs in the CHGE European sample.

(C) Allele frequency and 95% CIs in individuals highly exposed to SARS-CoV-2 who never tested positive (“Resistors,” n = 291) and in children with SARS-CoV-2 infection complicated by multisystem inflammatory syndrome (“MIS-C,” n = 235) from the European CHGE sample.

(D) Allele frequency and 95% CIs in Middle Eastern (ME) individuals from the CHGE cohort (Symptomatic, n = 895; Asymptomatic, n = 37).